Company Filing History:
Years Active: 1998-2003
Title: Innovations of John G Manns
Introduction
John G Manns is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of immunology through his innovative work. With a total of six patents to his name, Manns has focused on developing new immunological carrier systems that enhance immune responses.
Latest Patents
Manns' latest patents include groundbreaking work on polynucleotides encoding LKT 111. These patents disclose new immunological carrier systems and the DNA encoding them. The carrier systems consist of chimeric proteins that include a leukotoxin polypeptide fused to selected GnRH multimers. These multimers comprise at least one repeating GnRH decapeptide sequence or a sequence corresponding to an epitope of a selected GnRH molecule. The invention allows for the selected GnRH sequences to be the same or to correspond to different derivatives, analogues, variants, or epitopes of GnRH, provided they can elicit an immune response. The leukotoxin enhances the immunogenicity of the GnRH multimers fused to it.
Career Highlights
Throughout his career, John G Manns has worked with esteemed organizations such as the University of Saskatchewan and Biostar, Inc. His work has been pivotal in advancing the understanding and application of immunological carrier systems.
Collaborations
Manns has collaborated with notable colleagues, including Andrew A Potter and Gregg Patrick Adams. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
John G Manns is a distinguished inventor whose work in immunology has led to significant advancements in the field. His patents reflect a commitment to enhancing immune responses through innovative carrier systems.